|
|
Other links at Articles > HIV/AIDS |
| 1. |
Caution Urged in Drug Selection for HIV/TB Coinfection
|
|
|
Patients treated with rifampicin-based therapy for tuberculosis who begin a nevirapine-based regimen for HIV infection are twice as likely to develop viral failure as similar patients who start an efavirenz-based regimen. Reuters Health Information
|
| 2. |
FDA Safety Changes: Aygestin, Viracept, Dipentum
|
|
|
The FDA has approved revisions to the safety labeling for norethindrone acetate tablets (Aygestin), nelfinavir mesylate tablets and oral powder (Viracept), and olsalazine sodium capsules (Dipentum). Medscape Medical News
|
| 4. |
South African Court Bans AIDS Vitamin Trials
|
|
|
A South African court on Friday issued an order banning unauthorised clinical trials of vitamin therapies for AIDS conducted by a team including a former adviser to President Thabo Mbeki. Reuters Health Information
|
|
|